Ofloxacin Featured News
143 items
-
12
MarIvermectin opportunity is here
According to the World Health Organization, the parasite drug Ivermectin is used to treat patients with the new coronavirus -
11
MarRepresentatives of the National People's Congress of the Two Sessions: It is recommended to build a raw material medicine base in Tongliao, and build the largest corn biotechnology industrial base
Look at the "72 changes" of corn! Feng Yuzhen suggested to build a raw material medicine base in Tongliao to make the corn industry more "golden" -
11
MarThe three departments of the National Development and Reform Commission jointly issued the 'Cleaner Production Evaluation Index System for the Chemical API Industry' to be implemented on April 1
According to news from the National Development and Reform Commission on March 9, the National Development and Reform Commission, the Ministry of Ecology and Environment -
10
MarThe Indian pharmaceutical market is expected to grow to 130 billion U.S. dollars by 2030
The “6th Annual Conference of the Pharmaceutical and Medical Device Industry” and the “Pharmaceutical and Medical Device Industry Conference” -
10
MarAmicogen (China) Biopharmaceutical Co., Ltd. high-end API technical transformation project adjusted from 255 tons to 225 tons/year
According to the relevant requirements of the "Environmental Impact Assessment Public Participation Measures" (Ministry of Ecology and Environment Order No. 4) -
5
MarIndia's pharmaceutical industry outlook in the post-epidemic era
The Covid-19 epidemic is not only a sudden global health crisis, it has also been shown to cause serious damage to many industries. -
2
MarHongyuan Pharmaceuticals will achieve operating income of 1.3 billion yuan in 2020, and net profit will drop by 18.1% year-on-year
On March 1, Hubei Hongyuan Pharmaceutical Technology Co., Ltd. released its 2020 annual report. The company's metronidazole, benzoyl metronidazole raw materials, pharmaceutical intermediates. -
2
MarHongyuan Pharmaceutical achieves 878 million yuan in operating income for APIs and pharmaceutical intermediates in 2020
On March 1, Hubei Hongyuan Pharmaceutical Technology Co., Ltd. released its 2020 annual report. -
2
MarHubei Hongyuan Pharmaceutical Technology Company's production and sales of metronidazole APIs in 2020
-
25
FebIndian pharmaceutical companies are still actively seeking to get rid of their dependence on Chinese API imports
Under the pretext of worrying about "supply security," many Indian pharmaceutical companies claim to seek to reduce their dependence on China. -
23
FebTwo sessions of Hebei in 2021: the innovative development of pharmaceutical raw materials companies should be vigorously supported
Pharmaceuticals are the most basic link in the pharmaceutical industry chain. -
20
FebWith a total investment of 1.6 billion yuan, Wuxue Hongyuan Pharmaceutical Co., Ltd. makes great efforts in the Year of the Ox
Wuxue Hongyuan Pharmaceutical Co., Ltd. is an investment promotion project of the Party Working Committee of Tianjia Town Street, with a total investment of 1.6 billion yuan and an area of 650 mu. -
18
FebZhejiang Pharmaceutical Subsidiary Changhai Pharmaceutical's daptomycin API passed the U.S. FDA on-site inspection
On February 11, 2021, Changhai Pharmaceutical received a notification letter from the FDA and an on-site inspection report (EIR) issued for this inspection. -
18
FebSuihua Economic and Technological Development Zone normalizes epidemic prevention and control, and promotes the resumption of work and production of enterprises (Xinhecheng)
Qu Min, Secretary of the Municipal Party Committee and Commander-in-Chief of the Municipal Epidemic Prevention and Control Emergency Headquarters, went to Suihua Economic and Technological Development Zone. -
5
FebZhejiang Anglikang Pharmaceutical's annual production of 2.17 billion biomedical preparations project will be put into production soon
Zhejiang Anglikang Pharmaceutical Co., Ltd. has an annual output of 2.17 billion tablets (capsules/sticks/bags) of biomedical preparations industrialization project. -
31
JanGeneral Administration of Market Supervision: Simcere was fined more than 100 million yuan for monopolistic sales of raw materials of Batroxobin
100 million yuan is just a "small goal" in the mouth of some tycoons, but in the eyes of ordinary people, this is definitely a huge number, and it is not an exaggeration to describe it as an "astronomical figure". -
27
JanCangzhou Bohai New District Biomedicine Industrial Park API companies rush for deadlines, trial production, and rush orders
Grabbing construction schedules, installing equipment, trial production, rushing orders. -
27
JanChina's new technology helps the bio-fermentation industry continue to 'ferment'
The annual output and export volume have increased significantly. The new technology-assisted bio-fermentation industry continued to "ferment" from 24.26 million tons in 2015 to 30.647 million tons in 2019. -
27
JanThe Cleaner Production Evaluation Index System for the Chemical API Industry' will be implemented on April 1st
Notice of the National Development and Reform Commission on Printing and Distributing the Cleaner Production Evaluation Index System for the Chemical Raw Material Medicine Industry Development and Reform Huanzi Gui [2020] No. 1983. -
26
Jan2021 Jilin Two Sessions 'A substantial increase in raw materials and its impact on preparation manufacturers'
Dialogue with CPPCC member Xiu Yuan
Breaking News
-
Methanol Weekly Report (August 31, 2026 - September 06, 2026)
Sep 7 -
Styrene Weekly Report (August 31, 2026 - September 06, 2026)
Sep 7 -
Tianjin Haijing Polyamide 6 Slice Price News (2026-09-09)
Sep 9 -
Benzene Weekly Report (August 31, 2026 - September 06, 2026)
Sep 7 -
[Styrene]: September 9, 2026 Asian Market Styrene Price Dynamics
Sep 9 -
[PPC]: Zhejiang Huafeng Environmental PPC Price News (2026-09-09)
Sep 9
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)